Pavlovsky, C., Cordoba, B. V., Sanchez, M. B., Moiraghi, B., Varela, A., Custidiano, R., . . . Bianchini, M. (2023). Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal. BMC.
Chicago Style (17th ed.) CitationPavlovsky, Carolina, et al. Elevated Plasma Levels of IL-6 and MCP-1 Selectively Identify CML Patients Who Better Sustain Molecular Remission After TKI Withdrawal. BMC, 2023.
MLA (9th ed.) CitationPavlovsky, Carolina, et al. Elevated Plasma Levels of IL-6 and MCP-1 Selectively Identify CML Patients Who Better Sustain Molecular Remission After TKI Withdrawal. BMC, 2023.
Warning: These citations may not always be 100% accurate.